Freestone Grove Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Industrials | 12.27% |
| 4 | Healthcare | 11.72% |
| 5 | Consumer Discretionary | 10.21% |
Similar funds
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners deployed $589M of net new capital in Q1 2026, opening 515 new positions and adding to 214 existing holdings. Its largest new stake was Citigroup: 1,180,436 shares worth $134M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $303M trimmed.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.